Alpha Cognition Net Acquisitions/Divestitures 2020-2025 | ACOG
Alpha Cognition Annual Net Acquisitions/Divestitures (Millions of US $) |
|
---|---|
2024 | $N/A |
2023 | $N/A |
2022 | $N/A |
2021 | $N/A |
2020 | $N/A |
2019 | $N/A |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical - Biomedical and Genetics | $0.134B | $0.000B |
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Amgen (AMGN) | United States | $154.892B | 13.19 |
CSL (CSLLY) | Australia | $67.141B | 0.00 |
Alnylam Pharmaceuticals (ALNY) | United States | $58.528B | 0.00 |
Abivax SA (ABVX) | France | $6.124B | 0.00 |
Alkermes (ALKS) | Ireland | $4.782B | 13.29 |
CRISPR Therapeutics AG (CRSP) | Switzerland | $4.714B | 0.00 |
ACADIA Pharmaceuticals (ACAD) | United States | $4.385B | 40.61 |
ADMA Biologics Inc (ADMA) | United States | $4.119B | 29.76 |
Ascentage Pharma Group - (AAPG) | China | $3.948B | 0.00 |
Arcellx (ACLX) | United States | $3.848B | 0.00 |
Akero Therapeutics (AKRO) | United States | $3.738B | 0.00 |
Apellis Pharmaceuticals (APLS) | United States | $3.482B | 0.00 |
Alvotech (ALVO) | Luxembourg | $2.433B | 18.34 |
Agios Pharmaceuticals (AGIO) | United States | $2.191B | 0.00 |
ANI Pharmaceuticals (ANIP) | United States | $2.029B | 18.19 |
Adaptive Biotechnologies (ADPT) | United States | $2.007B | 0.00 |
Apogee Therapeutics (APGE) | United States | $1.677B | 0.00 |
Celldex Therapeutics (CLDX) | United States | $1.466B | 0.00 |
Cogent Biosciences (COGT) | United States | $1.375B | 0.00 |
AbCellera Biologics (ABCL) | Canada | $1.249B | 0.00 |
CureVac (CVAC) | Germany | $1.205B | 5.59 |
CorMedix Inc (CRMD) | United States | $1.107B | 19.77 |
Arbutus Biopharma (ABUS) | United States | $0.711B | 0.00 |
Castle Biosciences (CSTL) | United States | $0.696B | 68.60 |
AnaptysBio (ANAB) | United States | $0.569B | 0.00 |
Cytek Biosciences (CTKB) | United States | $0.527B | 0.00 |
Alumis (ALMS) | United States | $0.483B | 0.00 |
Compass Therapeutics (CMPX) | United States | $0.483B | 0.00 |
Corvus Pharmaceuticals (CRVS) | United States | $0.428B | 0.00 |
Absci (ABSI) | United States | $0.357B | 0.00 |
Abeona Therapeutics (ABEO) | United States | $0.350B | 7.42 |
ADC Therapeutics SA (ADCT) | Switzerland | $0.345B | 0.00 |
CytomX Therapeutics (CTMX) | United States | $0.336B | 3.64 |
Amarin (AMRN) | Ireland | $0.311B | 0.00 |
Contineum Therapeutics (CTNM) | United States | $0.293B | 0.00 |
Allogene Therapeutics (ALLO) | United States | $0.251B | 0.00 |
Alector (ALEC) | United States | $0.238B | 0.00 |
Annexon (ANNX) | United States | $0.226B | 0.00 |
Adocia (ADOCY) | France | $0.216B | 0.00 |
AC Immune (ACIU) | Switzerland | $0.205B | 0.00 |
Aardvark Therapeutics (AARD) | United States | $0.180B | 0.00 |
Actuate Therapeutics (ACTU) | United States | $0.175B | 0.00 |
Caribou Biosciences (CRBU) | United States | $0.174B | 0.00 |
Citius Oncology (CTOR) | United States | $0.170B | 0.00 |
Climb Bio (CLYM) | United States | $0.151B | 0.00 |
Cellectis S.A (CLLS) | France | $0.143B | 0.00 |
Cardiff Oncology (CRDF) | United States | $0.140B | 0.00 |
Anika Therapeutics (ANIK) | United States | $0.135B | 0.00 |
Coherus Oncology (CHRS) | United States | $0.135B | 0.00 |
Agenus (AGEN) | United States | $0.133B | 0.00 |
Connect Biopharma Holdings (CNTB) | United States | $0.115B | 0.00 |
Coya Therapeutics (COYA) | United States | $0.110B | 0.00 |
Anebulo Pharmaceuticals (ANEB) | United States | $0.103B | 0.00 |
Adagene (ADAG) | China | $0.100B | 0.00 |
Alto Neuroscience (ANRO) | United States | $0.100B | 0.00 |
ANIXA BIOSCIENCES INC (ANIX) | United States | $0.096B | 0.00 |
CervoMed (CRVO) | United States | $0.089B | 0.00 |
Acumen Pharmaceuticals (ABOS) | United States | $0.082B | 0.00 |
Applied Therapeutics (APLT) | United States | $0.071B | 0.00 |
ABVC BioPharma (ABVC) | United States | $0.067B | 0.00 |
Aligos Therapeutics (ALGS) | United States | $0.065B | 0.00 |
Adverum Biotechnologies (ADVM) | United States | $0.065B | 0.00 |
Coeptis Therapeutics Holdings (COEP) | United States | $0.064B | 0.00 |
ALX Oncology Holdings (ALXO) | United States | $0.063B | 0.00 |
Adlai Nortye (ANL) | Cayman Islands | $0.062B | 0.00 |
Cue Biopharma (CUE) | United States | $0.060B | 0.00 |
Adicet Bio (ACET) | United States | $0.060B | 0.00 |
Clene (CLNN) | United States | $0.053B | 0.00 |
Annovis Bio (ANVS) | United States | $0.045B | 0.00 |
CollPlant Biotechnologies (CLGN) | Israel | $0.033B | 0.00 |
AN2 Therapeutics (ANTX) | United States | $0.030B | 0.00 |
Clearside Biomedical (CLSD) | United States | $0.029B | 0.00 |
Cadrenal Therapeutics (CVKD) | United States | $0.027B | 0.00 |
Akari Therapeutics (AKTX) | United Kingdom | $0.024B | 0.00 |
Allarity Therapeutics (ALLR) | United States | $0.023B | 0.00 |
Cingulate (CING) | United States | $0.022B | 0.00 |
Curis (CRIS) | United States | $0.021B | 0.00 |
Abpro Holdings (ABP) | United States | $0.020B | 0.00 |
Cuprina Holdings (Cayman) (CUPR) | Singapore | $0.019B | 0.00 |
Adaptimmune Therapeutics (ADAP) | United Kingdom | $0.016B | 0.00 |
Cocrystal Pharma (COCP) | United States | $0.015B | 0.00 |
Chemomab Therapeutics (CMMB) | Israel | $0.015B | 0.00 |
COSCIENS Biopharma (CSCI) | Canada | $0.010B | 0.00 |
Advanced Biomed (ADVB) | United States | $0.009B | 0.00 |
Adial Pharmaceuticals (ADIL) | United States | $0.008B | 0.00 |
Avalon GloboCare (ALBT) | United States | $0.008B | 0.00 |
Acurx Pharmaceuticals (ACXP) | United States | $0.007B | 0.00 |
Alzamend Neuro (ALZN) | United States | $0.007B | 0.00 |
Apollomics (APLM) | United States | $0.004B | 0.00 |
CNS Pharmaceuticals (CNSP) | United States | $0.004B | 0.00 |
Aceragen (ACGN) | United States | $0.000B | 0.00 |
Clovis Oncology (CLVSQ) | United States | $0.000B | 0.00 |